Heron Therapeutics, Inc. (HRTX) News
Latest headlines that mention HRTX, newest first · each headline opens the original publisher
- Last price
- $0.37
- Day change
- +26.48%
- Next earnings
- 2026-11-09 BMO
HRTX headlines
latest coverageNot much coverage yet. HRTX has appeared in only a few headlines lately; new stories show up here as publishers cover it.
Patent setback forces guidance withdrawal as acute care revenue surges 44% year over year.
Image source: The Motley Fool. Monday, May 11, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
HRTX news alerts
Get an alert by email or push when a new headline mentions HRTX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.